BRPI0919759A2 - polipeptídeos para tratamento e prevenção de adesões - Google Patents
polipeptídeos para tratamento e prevenção de adesõesInfo
- Publication number
- BRPI0919759A2 BRPI0919759A2 BRPI0919759A BRPI0919759A BRPI0919759A2 BR PI0919759 A2 BRPI0919759 A2 BR PI0919759A2 BR PI0919759 A BRPI0919759 A BR PI0919759A BR PI0919759 A BRPI0919759 A BR PI0919759A BR PI0919759 A2 BRPI0919759 A2 BR PI0919759A2
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptides
- prevention
- adhesion treatment
- adhesion
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10683408P | 2008-10-20 | 2008-10-20 | |
PCT/US2009/061345 WO2010065206A1 (en) | 2008-10-20 | 2009-10-20 | Polypeptide for treating or preventing adhesions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0919759A2 true BRPI0919759A2 (pt) | 2017-03-21 |
Family
ID=42108870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0919759A BRPI0919759A2 (pt) | 2008-10-20 | 2009-10-20 | polipeptídeos para tratamento e prevenção de adesões |
Country Status (11)
Country | Link |
---|---|
US (1) | US9034815B2 (pt) |
EP (1) | EP2349310B1 (pt) |
JP (1) | JP5785085B2 (pt) |
KR (2) | KR101884616B1 (pt) |
CN (1) | CN102256613B (pt) |
AU (1) | AU2009322865B2 (pt) |
BR (1) | BRPI0919759A2 (pt) |
CA (1) | CA2741302C (pt) |
DK (1) | DK2349310T3 (pt) |
ES (1) | ES2507496T3 (pt) |
WO (1) | WO2010065206A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007342674B2 (en) | 2007-01-10 | 2013-09-19 | Purdue Research Foundation | Polypeptide inhibitors of HSP27 kinase and uses therefor |
JP5703466B2 (ja) | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | キナーゼ阻害薬およびその使用 |
JP6108660B2 (ja) | 2008-12-10 | 2017-04-05 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | 細胞透過性ペプチドを用いたキナーゼ阻害剤 |
WO2011017132A2 (en) | 2009-07-27 | 2011-02-10 | Purdue Research, Foundation | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
EP2575855A4 (en) * | 2010-05-24 | 2014-03-12 | Moerae Matrix Inc | METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE |
CN104302310A (zh) * | 2011-04-12 | 2015-01-21 | 莫伊莱麦屈克斯公司 | 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病、病状或病程的组合物和方法 |
US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
WO2013134636A1 (en) | 2012-03-09 | 2013-09-12 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
US9446090B2 (en) | 2012-03-23 | 2016-09-20 | Amicrobe, Inc. | Compositions and uses of antimicrobial materials with tissue-compatible properties |
US20140072613A1 (en) * | 2012-09-10 | 2014-03-13 | Cynthia Lander | Compositions and Methods for Treating Cutaneous Scarring |
WO2016061145A1 (en) * | 2014-10-13 | 2016-04-21 | Symic Biomedical, Inc. | Synthetic proteoglycans for preventing tissue adhesion |
RU2017121090A (ru) * | 2014-11-17 | 2018-12-20 | Мори Матрикс, Инк. | Композиции и способы для профилактики или лечения заболеваний, состояний или процессов, характеризующихся аберрантной пролиферацией фибробластов и накоплением внеклеточного матрикса |
MX2017008994A (es) | 2015-01-08 | 2018-09-18 | Moerae Matrix Inc | Formulacion de peptidos inhibidores mk2. |
AU2016229017A1 (en) | 2015-03-12 | 2017-09-28 | Moerae Matrix, Inc. | Use of MK2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same |
AU2018249552A1 (en) | 2017-04-06 | 2019-10-31 | Amicrobe, Inc. | Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety |
RU2741247C1 (ru) * | 2020-10-13 | 2021-01-22 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) | Способ профилактики перитонеальных спаек женского таза |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1521000A (en) * | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device |
US4227522A (en) * | 1978-09-05 | 1980-10-14 | Syntex Puerto Rico, Inc. | Inhalation device |
US4192309A (en) * | 1978-09-05 | 1980-03-11 | Syntex Puerto Rico, Inc. | Inhalation device with capsule opener |
AU570013B2 (en) * | 1982-10-08 | 1988-03-03 | Glaxo Group Limited | Medicament inhaler |
US4778054A (en) * | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
CA1272917A (en) * | 1985-07-30 | 1990-08-21 | Paul Kenneth Rand | Devices for administering medicaments to patients |
JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
AU4115693A (en) | 1992-04-24 | 1993-11-29 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
WO1995015972A1 (en) * | 1993-12-09 | 1995-06-15 | Thomas Jefferson University | Compounds and methods for site-directed mutations in eukaryotic cells |
AU2003260668A1 (en) * | 2002-04-01 | 2003-10-20 | Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University | Biological affinity based delivery systems |
WO2006071456A2 (en) * | 2004-12-02 | 2006-07-06 | The University Of North Carolina At Chapel Hill | Inhibition of hsp27 phosphorylation for treatment of blistering disorders |
CA2601823C (en) * | 2005-04-15 | 2016-01-12 | University Of Arizona | Therapeutic peptides for the treatment of metastatic cancer |
US20080293640A1 (en) * | 2007-01-10 | 2008-11-27 | Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of | Polypeptide inhibitors of HSP27 kinase and uses therefor |
AU2007342674B2 (en) * | 2007-01-10 | 2013-09-19 | Purdue Research Foundation | Polypeptide inhibitors of HSP27 kinase and uses therefor |
WO2008109794A2 (en) * | 2007-03-08 | 2008-09-12 | Tufts Medical Center | The role of the mk2 pathway in treating fibrosis and scarring |
JP5703466B2 (ja) * | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | キナーゼ阻害薬およびその使用 |
WO2009123759A2 (en) * | 2008-04-02 | 2009-10-08 | Moerae Matrix, Inc. | Therapeutic uses of biocompatible biogel compositions |
-
2009
- 2009-10-20 CA CA2741302A patent/CA2741302C/en not_active Expired - Fee Related
- 2009-10-20 AU AU2009322865A patent/AU2009322865B2/en not_active Ceased
- 2009-10-20 BR BRPI0919759A patent/BRPI0919759A2/pt not_active Application Discontinuation
- 2009-10-20 JP JP2011533273A patent/JP5785085B2/ja not_active Expired - Fee Related
- 2009-10-20 US US12/582,516 patent/US9034815B2/en not_active Expired - Fee Related
- 2009-10-20 ES ES09830789.5T patent/ES2507496T3/es active Active
- 2009-10-20 DK DK09830789.5T patent/DK2349310T3/da active
- 2009-10-20 CN CN200980148561.3A patent/CN102256613B/zh not_active Expired - Fee Related
- 2009-10-20 EP EP09830789.5A patent/EP2349310B1/en not_active Not-in-force
- 2009-10-20 KR KR1020117011373A patent/KR101884616B1/ko active IP Right Grant
- 2009-10-20 KR KR1020167036610A patent/KR20170001756A/ko not_active Application Discontinuation
- 2009-10-20 WO PCT/US2009/061345 patent/WO2010065206A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2741302C (en) | 2017-02-28 |
EP2349310B1 (en) | 2014-07-23 |
US20130101671A9 (en) | 2013-04-25 |
JP5785085B2 (ja) | 2015-09-24 |
KR20170001756A (ko) | 2017-01-04 |
EP2349310A1 (en) | 2011-08-03 |
AU2009322865A1 (en) | 2010-06-10 |
CN102256613A (zh) | 2011-11-23 |
AU2009322865B2 (en) | 2013-07-18 |
DK2349310T3 (da) | 2014-08-11 |
JP2012506442A (ja) | 2012-03-15 |
ES2507496T3 (es) | 2014-10-15 |
KR101884616B1 (ko) | 2018-08-06 |
CN102256613B (zh) | 2014-09-10 |
WO2010065206A1 (en) | 2010-06-10 |
KR20110095867A (ko) | 2011-08-25 |
EP2349310A4 (en) | 2012-11-21 |
CA2741302A1 (en) | 2010-06-10 |
US20100098760A1 (en) | 2010-04-22 |
US9034815B2 (en) | 2015-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919759A2 (pt) | polipeptídeos para tratamento e prevenção de adesões | |
HUS2300039I1 (hu) | PSMA-kötõ szerek és alkalmazásaik | |
BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
BRPI0917089A2 (pt) | métodos e sistemas planos de ação personalizados | |
BRPI0809978A2 (pt) | Dispositivos e métodos de dispensação de gotículas | |
BRPI0820379A2 (pt) | Sistemas e métodos de dispensação de produto médico | |
BRPI0815588A2 (pt) | Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano | |
BRPI0806964A2 (pt) | Combinações de agonístico beta-2-adrenoceptor e benzotiazolona | |
DK2405869T3 (da) | Fedmebehandling | |
BRPI0910259A2 (pt) | métodos de tratamento de inflamação | |
IL207096A0 (en) | Modified leptin polypeptides and their uses | |
BRPI1015379A2 (pt) | sistemas de cálculo biométrico e métodos | |
BRPI0908379A2 (pt) | sistemas e métodos para obter dentaduras customizadas | |
BRPI1016199A2 (pt) | cobertura de ferimento e kit de tratamento de ferimentos. | |
BRPI0917288A2 (pt) | sensor de biomems e aparelhos e métodos para o mesmo | |
BR112012004281A2 (pt) | uso de metformina tratamento e prevenção de câncer | |
BRPI0905715A2 (pt) | Composição farmacêutica e kit de componentes | |
BRPI0811870A2 (pt) | Tratamento e prevenção de influenza | |
BRPI0816789A2 (pt) | Goji e inflamação | |
BRPI0816288A2 (pt) | Processos e compostos | |
ZA201100019B (en) | Variant hhip1 protein and methods and uses thereof | |
BRPI0806944A2 (pt) | Medicamento para o tratamento de endometriose | |
DK2154144T3 (da) | Oligonukleotider og anvendelse deraf | |
BRPI0812105A2 (pt) | Neramexano para o tratamento de nistagmo | |
DK2310037T3 (da) | Conglutin-gamma as-medikament og -kosttilskudpatentkrav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |